Results 181 to 189 of about 6,571 (189)

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Diabetes, Obesity and Metabolism, 2010
Y Iwamoto
exaly  

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin

Diabetes, Obesity and Metabolism, 2009
Francesco Dotta
exaly  

Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers

Journal of Clinical Pharmacology, 2007
Yan-Ling He, Gangadhar Sunkara, Dan Howard   +2 more
exaly  

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial – a primary care, type 2 diabetes study

Diabetes, Obesity and Metabolism, 2009
D Purkayastha, S Dagogo-Jack
exaly  

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Endocrine Journal, 2011
Masanori Abe, Noriaki Maruyama, Terumi Higuchi   +2 more
exaly  

Vildagliptin

Drugs of the Future, 2004
null McIntyre, J.A., null Castaner, J.
openaire   +1 more source

Vildagliptin

Reactions Weekly, 2015
openaire   +1 more source

Vildagliptin protects endothelial cells against high glucose-induced damage

Biomedicine and Pharmacotherapy, 2018
exaly  

P19-52 In silico and in vitro genotoxicity evaluation of vildagliptin impurities: vildagliptin cyclic amidine, vildagliptin diketopiperazine and vildagliptine amide

Toxicology Letters
M. Hamitoğlu, G. Tugcu, A.G. Kılıç, G. Esen, A. Aydın   +4 more
openaire   +1 more source